IL108218A0 - Benzanilide derivatives, their preparation and pharmaceutical compositions containing them - Google Patents
Benzanilide derivatives, their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL108218A0 IL108218A0 IL10821893A IL10821893A IL108218A0 IL 108218 A0 IL108218 A0 IL 108218A0 IL 10821893 A IL10821893 A IL 10821893A IL 10821893 A IL10821893 A IL 10821893A IL 108218 A0 IL108218 A0 IL 108218A0
- Authority
- IL
- Israel
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- benzanilide derivatives
- benzanilide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB929227125A GB9227125D0 (en) | 1992-12-30 | 1992-12-30 | Chemical compounds |
GB929227116A GB9227116D0 (en) | 1992-12-30 | 1992-12-30 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL108218A0 true IL108218A0 (en) | 1994-04-12 |
Family
ID=26302242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL10821893A IL108218A0 (en) | 1992-12-30 | 1993-12-29 | Benzanilide derivatives, their preparation and pharmaceutical compositions containing them |
Country Status (5)
Country | Link |
---|---|
CN (1) | CN1094037A (en) |
AU (1) | AU5815594A (en) |
IL (1) | IL108218A0 (en) |
TW (1) | TW240217B (en) |
WO (1) | WO1994015920A1 (en) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995015954A1 (en) * | 1993-12-07 | 1995-06-15 | Smithkline Beecham Plc | Heterocyclic biphenylylamides useful as 5ht1d antagonists |
GB9507203D0 (en) * | 1995-04-07 | 1995-05-31 | Smithkline Beecham Plc | Novel compounds |
FR2740134B1 (en) * | 1995-10-18 | 1998-01-09 | Pf Medicament | CYCLIC AMINE DERIVATIVES OF ARYL-PIPERAZINES, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
FR2744449B1 (en) * | 1996-02-02 | 1998-04-24 | Pf Medicament | NOVEL AROMATIC PIPERAZINES DERIVED FROM SUBSTITUTED CYCLOAZANES, AS WELL AS THEIR PREPARATION METHOD, PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS MEDICAMENTS |
FR2744450A1 (en) * | 1996-02-02 | 1997-08-08 | Pf Medicament | NOVEL NAPHTYLPIPERAZINES DERIVED FROM SUBSTITUTED CYCLOAZANES, AS WELL AS THEIR PREPARATION METHOD, PHARMACEUTICAL COMPOSITIONS AND THEIR USE AS MEDICAMENTS |
EP0946551A2 (en) * | 1996-12-19 | 1999-10-06 | Smithkline Beecham Plc | N-piperazin-1-ylphenyl-benzamide derivatives |
WO2000008001A1 (en) | 1998-08-07 | 2000-02-17 | Chiron Corporation | Substituted isoxazole as estrogen receptor modulators |
SE9904723D0 (en) * | 1999-12-22 | 1999-12-22 | Carlsson A Research Ab | New modulators of dopamine neurotransmission II |
PE20020506A1 (en) | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | PIRAZOLE DERIVATIVES FUSED AS PROTEIN KINASE INHIBITORS |
GB0124936D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124939D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124931D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124933D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124941D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124938D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124934D0 (en) | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
ATE485275T1 (en) | 2002-02-12 | 2010-11-15 | Glaxosmithkline Llc | NICOTINAMIDES AND THEIR USE AS P38 INHIBITORS |
GB0209891D0 (en) * | 2002-04-30 | 2002-06-05 | Glaxo Group Ltd | Novel compounds |
GB0217757D0 (en) | 2002-07-31 | 2002-09-11 | Glaxo Group Ltd | Novel compounds |
GB0308201D0 (en) | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
GB0308185D0 (en) | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
GB0308186D0 (en) | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
GB0318814D0 (en) | 2003-08-11 | 2003-09-10 | Smithkline Beecham Corp | Novel compounds |
JO3598B1 (en) | 2006-10-10 | 2020-07-05 | Infinity Discovery Inc | Boronic acids and esters as inhibitors of fatty acid amide hydrolase |
US7737149B2 (en) | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
TW201000107A (en) | 2008-04-09 | 2010-01-01 | Infinity Pharmaceuticals Inc | Inhibitors of fatty acid amide hydrolase |
CA2788587C (en) | 2010-02-03 | 2020-03-10 | Infinity Pharmaceuticals, Inc. | Fatty acid amide hydrolase inhibitors |
MY162689A (en) * | 2010-10-30 | 2017-07-14 | Lupin Ltd | Oxazoline and isoxazoline derivatives as crac modulators |
US20140179712A1 (en) | 2012-12-21 | 2014-06-26 | Astrazeneca Ab | Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide |
WO2019036024A1 (en) | 2017-08-17 | 2019-02-21 | Bristol-Myers Squibb Company | 2-(1,1 '-biphenyl)-1 h-benzo[d]imidazole derivatives and related compounds as apelin and apj agonists for treating cardiovascular diseases |
WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
DK4225753T3 (en) * | 2020-10-08 | 2024-08-19 | Leukos Biotech S L | Potent and selective compounds as modulators of serotonin-1B receptors |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2162792T3 (en) * | 1991-09-18 | 2002-01-16 | Glaxo Group Ltd | BENZANILIDE DERIVATIVES AS 5-HT1D ANTAGONISTS. |
-
1993
- 1993-12-27 TW TW082111006A patent/TW240217B/zh active
- 1993-12-28 AU AU58155/94A patent/AU5815594A/en not_active Abandoned
- 1993-12-28 WO PCT/EP1993/003708 patent/WO1994015920A1/en active Application Filing
- 1993-12-29 IL IL10821893A patent/IL108218A0/en unknown
- 1993-12-29 CN CN93121518.8A patent/CN1094037A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1094037A (en) | 1994-10-26 |
AU5815594A (en) | 1994-08-15 |
WO1994015920A1 (en) | 1994-07-21 |
TW240217B (en) | 1995-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL108218A0 (en) | Benzanilide derivatives, their preparation and pharmaceutical compositions containing them | |
IL103198A0 (en) | Benzanilide derivatives,their preparation and pharmaceutical compositions containing them | |
IL103197A0 (en) | Benzanilide derivatives,their preparation and pharmaceutical compositions containing them | |
IL103199A0 (en) | Benzanilide derivatives,their preparation and pharmaceutical compositions containing them | |
IL99225A0 (en) | 3-amidopyrazole derivatives,their preparation and pharmaceutical compositions containing them | |
IL101864A0 (en) | Thiopyranopyrrole derivatives,their preparation and pharmaceutical compositions containing them | |
IL104447A0 (en) | 1,5-benzodiazepine derivatives,their preparation and pharmaceutical compositions containing them | |
IL104445A0 (en) | Piperidine derivatives,their preparation and pharmaceutical compositions containing them | |
IL106141A0 (en) | Thiazolylvinylphenyl derivatives,their manufacture and pharmaceutical compositions containing them | |
IL108729A0 (en) | Pyrrolo-pyridine derivatives, their preparation and pharmaceutical compositions containing them | |
IL106904A0 (en) | Thiazolidine derivatives,their preparation and pharmaceutical compositions containing them | |
IL100262A0 (en) | Alpha-oxoacetamide derivatives,their preparation and pharmaceutical compositions containing them | |
IL104843A0 (en) | Sulphonylbenzyl-substituted pyridones,their preparation and pharmaceutical compositions containing them | |
IL101380A0 (en) | Bis-naphthalimides,their preparation and pharmaceutical compositions containing them | |
IL97050A0 (en) | 4-isoxazolecarboxamide derivatives,pharmaceutical compositions containing them and their preparation | |
IL105976A0 (en) | Biphenyl derivatives,their preparation and pharmaceutical compositions containing them | |
IL98542A0 (en) | Benzoquinazoline derivatives,their preparation and pharmaceutical compositions containing them | |
IL108703A0 (en) | Substituted azolone derivatives, their preparation and pharmaceutical compositions containing them | |
IL104356A0 (en) | Benzofuranyl-and thiophenylmethylthio-alkanecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them | |
IL105716A0 (en) | Aminopropanol derivatives,their preparation and pharmaceutical compositions containing them | |
IL105647A0 (en) | Biphenylmethyl-substituted pyridones,their preparation and pharmaceutical compositions containing them | |
IL102500A0 (en) | 3-deoxy-mannosamine derivatives,their preparation and pharmaceutical compositions containing them | |
ZA948689B (en) | New taxicin derivatives their preparation and pharmaceutical compositions containing them | |
IL105774A0 (en) | Thienothiazine derivatives,their preparation and pharmaceutical compositions containing them | |
ZA933426B (en) | New dihydroxybenzylamine derivatives their preparation and pharmaceutical compositions which contain them |